Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Salivary hypersecretion
ADR ID BADD_A03914
ADR Hierarchy
07      Gastrointestinal disorders
07.06      Salivary gland conditions
07.06.01      Oral dryness and saliva altered
07.06.01.009      Salivary hypersecretion
Description Increased salivary flow. [MeSH]
MedDRA Code 10039424
MeSH ID D012798; D012472
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hypersalivation | Increased salivation | Ptyalism | Saliva increased | Saliva secretion excessive | Saliva secretion increased | Salivary hypersecretion | Salivation | Sialorrhoea | Sialorrhea | Hypersialosis | Drooling
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01177Iodipamide meglumine--
BADD_D01178Iodixanol--
BADD_D01180Iohexol0.010670%
BADD_D01182Iopromide0.021340%
BADD_D01186Ioversol0.026320%
BADD_D01191Ipratropium0.000138%
BADD_D01195Irinotecan--
BADD_D01196Irinotecan hydrochloride--
BADD_D01203Isoflurane--
BADD_D01228Ketamine0.000447%
BADD_D01231Ketoprofen--
BADD_D01238Lacosamide0.004680%
BADD_D01243Lamotrigine0.000342%
BADD_D01245Lansoprazole--
BADD_D01265Levetiracetam0.000549%
BADD_D01275Levofloxacin0.000063%
BADD_D01285Levothyroxine0.000010%
BADD_D01300Lisinopril--
BADD_D01303Lithium carbonate0.000803%
BADD_D01304Lithium cation0.000518%
BADD_D01305Lithium hydroxide--
BADD_D01317Loratadine--
BADD_D01318Lorazepam--
BADD_D01322Losartan0.000010%
BADD_D01326Loxapine--
BADD_D01327Loxapine succinate--
BADD_D01330Lurasidone0.000885%
BADD_D01331Lurasidone hydrochloride--
BADD_D01345Magnevist--
BADD_D01350Maprotiline--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 10 Pages